Market Executive Summary
Market Analysis and Insights: Global and United States GLP-1 Drug Market
This report focuses on global and United States GLP-1 Drug market, also covers the segmentation data of other regions in regional level and county level.
The global GLP-1 Drug revenue was US$ 20430 million in 2022 and is forecast to a readjusted size of US$ 99940 million by 2029 with a CAGR of 25.7% during the forecast period (2023-2029).
In United States the GLP-1 Drug revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
The global key players of GLP-1 Drug include Eli Lilly, AstraZeneca, Sanofi, Pfizer Inc, Novo Nordisk, Boehringer Ingelheim, GlaxoSmithKline (GSK), East China Pharmaceutical Co., Ltd. and Gan & Lee Pharmaceuticals, etc. The global five biggest players hold a share of % in 2022.
Global GLP-1 Drug Scope and Market Size
GLP-1 Drug market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global GLP-1 Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For United States market, this report focuses on the GLP-1 Drug market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in United States.
By Company
Eli Lilly
AstraZeneca
Sanofi
Pfizer Inc
Novo Nordisk
Boehringer Ingelheim
GlaxoSmithKline (GSK)
East China Pharmaceutical Co., Ltd.
Gan & Lee Pharmaceuticals
Tonghua Dongbao
Shanghai Renhui Biopharmaceutical Co., Ltd.
Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
Segment by Type
Short-acting GLP-1 Drug
Long-acting GLP-1 Drug
Segment by Application
Obesity
Type 2 Diabetes (T2DM)
Cardiovascular and Cerebrovascular Diseases (CVD)
Non-alcoholic Steatohepatitis (NASH)
Alzheimer's Disease (AD)
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1: Introduces GLP-1 Drug definition, global sales (volume and revenue), United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Detailed analysis of GLP-1 Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Revenue and volume of GLP-1 Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6: Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7: EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8: China by type, by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, GLP-1 Drug sales, revenue, gross margin, and recent development, etc.
Chapter 11: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12: Research findings and conclusion
Table of Contents
1 Study Coverage
1.1 GLP-1 Drug Product Introduction
1.2 Global GLP-1 Drug Outlook 2018 VS 2022 VS 2029
1.2.1 Global GLP-1 Drug Sales in US$ Million for the Year 2018-2029
1.2.2 Global GLP-1 Drug Sales in Volume for the Year 2018-2029
1.3 United States GLP-1 Drug Outlook 2018 VS 2022 VS 2029
1.3.1 United States GLP-1 Drug Sales in US$ Million for the Year 2018-2029
1.3.2 United States GLP-1 Drug Sales in Volume for the Year 2018-2029
1.4 GLP-1 Drug Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of United States GLP-1 Drug in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of GLP-1 Drug Market Size, United States VS Global, 2018 VS 2022 VS 2029
1.5 GLP-1 Drug Market Dynamics
1.5.1 GLP-1 Drug Industry Trends
1.5.2 GLP-1 Drug Market Drivers
1.5.3 GLP-1 Drug Market Challenges
1.5.4 GLP-1 Drug Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 GLP-1 Drug by Type
2.1 GLP-1 Drug Market Segment by Type
2.1.1 Short-acting GLP-1 Drug
2.1.2 Long-acting GLP-1 Drug
2.2 Global GLP-1 Drug Market Size by Type
2.2.1 Global GLP-1 Drug Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global GLP-1 Drug Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global GLP-1 Drug Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 United States GLP-1 Drug Market Size by Type
2.3.1 United States GLP-1 Drug Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 United States GLP-1 Drug Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 United States GLP-1 Drug Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 GLP-1 Drug by Application
3.1 GLP-1 Drug Market Segment by Application
3.1.1 Obesity
3.1.2 Type 2 Diabetes (T2DM)
3.1.3 Cardiovascular and Cerebrovascular Diseases (CVD)
3.1.4 Non-alcoholic Steatohepatitis (NASH)
3.1.5 Alzheimer's Disease (AD)
3.2 Global GLP-1 Drug Market Size by Application
3.2.1 Global GLP-1 Drug Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global GLP-1 Drug Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global GLP-1 Drug Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 United States GLP-1 Drug Market Size by Application
3.3.1 United States GLP-1 Drug Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 United States GLP-1 Drug Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 United States GLP-1 Drug Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global GLP-1 Drug Competitor Landscape by Company
4.1 Global GLP-1 Drug Market Size by Company
4.1.1 Global Key Manufacturers of GLP-1 Drug, Ranked by Revenue (2022)
4.1.2 Global GLP-1 Drug Revenue by Manufacturer (2018-2023)
4.1.3 Global GLP-1 Drug Sales by Manufacturer (2018-2023)
4.1.4 Global GLP-1 Drug Price by Manufacturer (2018-2023)
4.2 Global GLP-1 Drug Concentration Ratio (CR)
4.2.1 GLP-1 Drug Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of GLP-1 Drug in 2022
4.2.3 Global GLP-1 Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of GLP-1 Drug, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of GLP-1 Drug, Product Offered and Application
4.5 Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 United States GLP-1 Drug Market Size by Company
4.7.1 Key Players of GLP-1 Drug in United States, Ranked by Revenue (2022)
4.7.2 United States GLP-1 Drug Revenue by Players (2018-2023)
4.7.3 United States GLP-1 Drug Sales by Players (2018-2023)
5 Global GLP-1 Drug Market Size by Region
5.1 Global GLP-1 Drug Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global GLP-1 Drug Market Size in Volume by Region (2018-2029)
5.2.1 Global GLP-1 Drug Sales in Volume by Region: 2018-2023
5.2.2 Global GLP-1 Drug Sales in Volume Forecast by Region (2024-2029)
5.3 Global GLP-1 Drug Market Size in Value by Region (2018-2029)
5.3.1 Global GLP-1 Drug Sales in Value by Region: 2018-2023
5.3.2 Global GLP-1 Drug Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas GLP-1 Drug Market Size YoY Growth 2018-2029
6.2 Americas GLP-1 Drug Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas GLP-1 Drug Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas GLP-1 Drug Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas GLP-1 Drug Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas GLP-1 Drug Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA GLP-1 Drug Market Size YoY Growth 2018-2029
7.2 EMEA GLP-1 Drug Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA GLP-1 Drug Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA GLP-1 Drug Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA GLP-1 Drug Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA GLP-1 Drug Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China GLP-1 Drug Market Size YoY Growth 2018-2029
8.2 China GLP-1 Drug Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China GLP-1 Drug Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC GLP-1 Drug Market Size YoY Growth 2018-2029
9.2 APAC GLP-1 Drug Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC GLP-1 Drug Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC GLP-1 Drug Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC GLP-1 Drug Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC GLP-1 Drug Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Information
10.1.2 Eli Lilly Description and Business Overview
10.1.3 Eli Lilly GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Eli Lilly GLP-1 Drug Products Offered
10.1.5 Eli Lilly Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Information
10.2.2 AstraZeneca Description and Business Overview
10.2.3 AstraZeneca GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.2.4 AstraZeneca GLP-1 Drug Products Offered
10.2.5 AstraZeneca Recent Development
10.3 Sanofi
10.3.1 Sanofi Company Information
10.3.2 Sanofi Description and Business Overview
10.3.3 Sanofi GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi GLP-1 Drug Products Offered
10.3.5 Sanofi Recent Development
10.4 Pfizer Inc
10.4.1 Pfizer Inc Company Information
10.4.2 Pfizer Inc Description and Business Overview
10.4.3 Pfizer Inc GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Pfizer Inc GLP-1 Drug Products Offered
10.4.5 Pfizer Inc Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Information
10.5.2 Novo Nordisk Description and Business Overview
10.5.3 Novo Nordisk GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Novo Nordisk GLP-1 Drug Products Offered
10.5.5 Novo Nordisk Recent Development
10.6 Boehringer Ingelheim
10.6.1 Boehringer Ingelheim Company Information
10.6.2 Boehringer Ingelheim Description and Business Overview
10.6.3 Boehringer Ingelheim GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Boehringer Ingelheim GLP-1 Drug Products Offered
10.6.5 Boehringer Ingelheim Recent Development
10.7 GlaxoSmithKline (GSK)
10.7.1 GlaxoSmithKline (GSK) Company Information
10.7.2 GlaxoSmithKline (GSK) Description and Business Overview
10.7.3 GlaxoSmithKline (GSK) GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.7.4 GlaxoSmithKline (GSK) GLP-1 Drug Products Offered
10.7.5 GlaxoSmithKline (GSK) Recent Development
10.8 East China Pharmaceutical Co., Ltd.
10.8.1 East China Pharmaceutical Co., Ltd. Company Information
10.8.2 East China Pharmaceutical Co., Ltd. Description and Business Overview
10.8.3 East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.8.4 East China Pharmaceutical Co., Ltd. GLP-1 Drug Products Offered
10.8.5 East China Pharmaceutical Co., Ltd. Recent Development
10.9 Gan & Lee Pharmaceuticals
10.9.1 Gan & Lee Pharmaceuticals Company Information
10.9.2 Gan & Lee Pharmaceuticals Description and Business Overview
10.9.3 Gan & Lee Pharmaceuticals GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Gan & Lee Pharmaceuticals GLP-1 Drug Products Offered
10.9.5 Gan & Lee Pharmaceuticals Recent Development
10.10 Tonghua Dongbao
10.10.1 Tonghua Dongbao Company Information
10.10.2 Tonghua Dongbao Description and Business Overview
10.10.3 Tonghua Dongbao GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Tonghua Dongbao GLP-1 Drug Products Offered
10.10.5 Tonghua Dongbao Recent Development
10.11 Shanghai Renhui Biopharmaceutical Co., Ltd.
10.11.1 Shanghai Renhui Biopharmaceutical Co., Ltd. Company Information
10.11.2 Shanghai Renhui Biopharmaceutical Co., Ltd. Description and Business Overview
10.11.3 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Products Offered
10.11.5 Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Development
10.12 Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
10.12.1 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
10.12.2 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Business Overview
10.12.3 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Products Offered
10.12.5 Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 GLP-1 Drug Industry Chain Analysis
11.2 GLP-1 Drug Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 GLP-1 Drug Production Mode & Process
11.4 GLP-1 Drug Sales and Marketing
11.4.1 GLP-1 Drug Sales Channels
11.4.2 GLP-1 Drug Distributors
11.5 GLP-1 Drug Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
List of Figures
List of Tables
Table 1. GLP-1 Drug CAGR in Value, United States VS Global, 2018 VS 2022 VS 2029
Table 2. GLP-1 Drug Market Trends
Table 3. GLP-1 Drug Market Drivers
Table 4. GLP-1 Drug Market Challenges
Table 5. GLP-1 Drug Market Restraints
Table 6. Global GLP-1 Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. United States GLP-1 Drug Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global GLP-1 Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. United States GLP-1 Drug Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 10. Global Key Manufacturers of GLP-1 Drug, Ranked by Revenue (2022) & (US$ Million)
Table 11. Global GLP-1 Drug Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global GLP-1 Drug Revenue Share by Manufacturer, 2018-2023
Table 13. Global GLP-1 Drug Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global GLP-1 Drug Sales Share by Manufacturer, 2018-2023
Table 15. Global GLP-1 Drug Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global GLP-1 Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global GLP-1 Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GLP-1 Drug as of 2022)
Table 18. Global Key Manufacturers of GLP-1 Drug, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of GLP-1 Drug, Product Offered and Application
Table 20. Global Key Manufacturers of GLP-1 Drug, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of GLP-1 Drug in United States, Ranked by Revenue (2022) & (US$ million)
Table 23. United States GLP-1 Drug Revenue by Players, (US$ Million), (2018-2023)
Table 24. United States GLP-1 Drug Revenue Share by Players, (2018-2023)
Table 25. United States GLP-1 Drug Sales by Players, (K Units), (2018-2023)
Table 26. United States GLP-1 Drug Sales Share by Players, (2018-2023)
Table 27. Global GLP-1 Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 28. Global GLP-1 Drug Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global GLP-1 Drug Sales in Volume Forecast by Region (2024-2029) & (K Units)
Table 30. Global GLP-1 Drug Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global GLP-1 Drug Sales in Value Forecast by Region (2024-2029) & (US$ Million)
Table 32. Americas GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. Americas GLP-1 Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas GLP-1 Drug Sales in Value by Country (2024-2029) & (US$ Million)
Table 35. Americas GLP-1 Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas GLP-1 Drug Sales in Volume by Country (2024-2029) & (K Units)
Table 37. EMEA GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. EMEA GLP-1 Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA GLP-1 Drug Sales in Value by Country (2024-2029) & (US$ Million)
Table 40. EMEA GLP-1 Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA GLP-1 Drug Sales in Volume by Country (2024-2029) & (K Units)
Table 42. APAC GLP-1 Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. APAC GLP-1 Drug Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC GLP-1 Drug Sales in Value by Country (2024-2029) & (US$ Million)
Table 45. APAC GLP-1 Drug Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC GLP-1 Drug Sales in Volume by Country (2024-2029) & (K Units)
Table 47. Eli Lilly Company Information
Table 48. Eli Lilly Description and Business Overview
Table 49. Eli Lilly GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Eli Lilly GLP-1 Drug Product
Table 51. Eli Lilly Recent Development
Table 52. AstraZeneca Company Information
Table 53. AstraZeneca Description and Business Overview
Table 54. AstraZeneca GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. AstraZeneca GLP-1 Drug Product
Table 56. AstraZeneca Recent Development
Table 57. Sanofi Company Information
Table 58. Sanofi Description and Business Overview
Table 59. Sanofi GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Sanofi GLP-1 Drug Product
Table 61. Sanofi Recent Development
Table 62. Pfizer Inc Company Information
Table 63. Pfizer Inc Description and Business Overview
Table 64. Pfizer Inc GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Pfizer Inc GLP-1 Drug Product
Table 66. Pfizer Inc Recent Development
Table 67. Novo Nordisk Company Information
Table 68. Novo Nordisk Description and Business Overview
Table 69. Novo Nordisk GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Novo Nordisk GLP-1 Drug Product
Table 71. Novo Nordisk Recent Development
Table 72. Boehringer Ingelheim Company Information
Table 73. Boehringer Ingelheim Description and Business Overview
Table 74. Boehringer Ingelheim GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Boehringer Ingelheim GLP-1 Drug Product
Table 76. Boehringer Ingelheim Recent Development
Table 77. GlaxoSmithKline (GSK) Company Information
Table 78. GlaxoSmithKline (GSK) Description and Business Overview
Table 79. GlaxoSmithKline (GSK) GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. GlaxoSmithKline (GSK) GLP-1 Drug Product
Table 81. GlaxoSmithKline (GSK) Recent Development
Table 82. East China Pharmaceutical Co., Ltd. Company Information
Table 83. East China Pharmaceutical Co., Ltd. Description and Business Overview
Table 84. East China Pharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. East China Pharmaceutical Co., Ltd. GLP-1 Drug Product
Table 86. East China Pharmaceutical Co., Ltd. Recent Development
Table 87. Gan & Lee Pharmaceuticals Company Information
Table 88. Gan & Lee Pharmaceuticals Description and Business Overview
Table 89. Gan & Lee Pharmaceuticals GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Gan & Lee Pharmaceuticals GLP-1 Drug Product
Table 91. Gan & Lee Pharmaceuticals Recent Development
Table 92. Tonghua Dongbao Company Information
Table 93. Tonghua Dongbao Description and Business Overview
Table 94. Tonghua Dongbao GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Tonghua Dongbao GLP-1 Drug Product
Table 96. Tonghua Dongbao Recent Development
Table 97. Shanghai Renhui Biopharmaceutical Co., Ltd. Company Information
Table 98. Shanghai Renhui Biopharmaceutical Co., Ltd. Description and Business Overview
Table 99. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Shanghai Renhui Biopharmaceutical Co., Ltd. GLP-1 Drug Product
Table 101. Shanghai Renhui Biopharmaceutical Co., Ltd. Recent Development
Table 102. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Company Information
Table 103. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Description and Business Overview
Table 104. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. GLP-1 Drug Product
Table 106. Jiangsu Hansoh Pharmaceutical Group Co., Ltd. Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. GLP-1 Drug Customers List
Table 110. GLP-1 Drug Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. GLP-1 Drug Product Picture
Figure 2. Global GLP-1 Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global GLP-1 Drug Market Size 2018-2029 (US$ Million)
Figure 4. Global GLP-1 Drug Sales 2018-2029 (K Units)
Figure 5. United States GLP-1 Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 6. United States GLP-1 Drug Market Size 2018-2029 (US$ Million)
Figure 7. United States GLP-1 Drug Sales 2018-2029 (K Units)
Figure 8. United States GLP-1 Drug Market Share in Global, in Value (US$ Million) 2018-2029
Figure 9. United States GLP-1 Drug Market Share in Global, in Volume (K Units) 2018-2029
Figure 10. GLP-1 Drug Report Years Considered
Figure 11. Product Picture of Short-acting GLP-1 Drug
Figure 12. Product Picture of Long-acting GLP-1 Drug
Figure 13. Global GLP-1 Drug Market Share by Type in 2022 & 2029
Figure 14. Global GLP-1 Drug Sales in Value by Type (2018-2029) & (US$ Million)
Figure 15. Global GLP-1 Drug Sales Market Share in Value by Type (2018-2029)
Figure 16. Global GLP-1 Drug Sales by Type (2018-2029) & (K Units)
Figure 17. Global GLP-1 Drug Sales Market Share in Volume by Type (2018-2029)
Figure 18. Global GLP-1 Drug Price by Type (2018-2029) & (US$/Unit)
Figure 19. United States GLP-1 Drug Market Share by Type in 2022 & 2029
Figure 20. United States GLP-1 Drug Sales in Value by Type (2018-2029) & (US$ Million)
Figure 21. United States GLP-1 Drug Sales Market Share in Value by Type (2018-2029)
Figure 22. United States GLP-1 Drug Sales by Type (2018-2029) & (K Units)
Figure 23. United States GLP-1 Drug Sales Market Share in Volume by Type (2018-2029)
Figure 24. United States GLP-1 Drug Price by Type (2018-2029) & (US$/Unit)
Figure 25. Product Picture of Obesity
Figure 26. Product Picture of Type 2 Diabetes (T2DM)
Figure 27. Product Picture of Cardiovascular and Cerebrovascular Diseases (CVD)
Figure 28. Product Picture of Non-alcoholic Steatohepatitis (NASH)
Figure 29. Product Picture of Alzheimer's Disease (AD)
Figure 30. Global GLP-1 Drug Market Share by Application in 2022 & 2029
Figure 31. Global GLP-1 Drug Sales in Value by Application (2018-2029) & (US$ Million)
Figure 32. Global GLP-1 Drug Sales Market Share in Value by Application (2018-2029)
Figure 33. Global GLP-1 Drug Sales by Application (2018-2029) & (K Units)
Figure 34. Global GLP-1 Drug Sales Market Share in Volume by Application (2018-2029)
Figure 35. Global GLP-1 Drug Price by Application (2018-2029) & (US$/Unit)
Figure 36. United States GLP-1 Drug Market Share by Application in 2022 & 2029
Figure 37. United States GLP-1 Drug Sales in Value by Application (2018-2029) & (US$ Million)
Figure 38. United States GLP-1 Drug Sales Market Share in Value by Application (2018-2029)
Figure 39. United States GLP-1 Drug Sales by Application (2018-2029) & (K Units)
Figure 40. United States GLP-1 Drug Sales Market Share in Volume by Application (2018-2029)
Figure 41. United States GLP-1 Drug Price by Application (2018-2029) & (US$/Unit)
Figure 42. Americas GLP-1 Drug Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 43. Americas GLP-1 Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 44. Americas GLP-1 Drug Sales by Type (2018-2029) & (K Units)
Figure 45. Americas GLP-1 Drug Sales Market Share in Volume by Type (2018-2029)
Figure 46. Americas GLP-1 Drug Sales by Application (2018-2029) & (K Units)
Figure 47. Americas GLP-1 Drug Sales Market Share in Volume by Application (2018-2029)
Figure 48. United States GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 49. Canada GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 50. Mexico GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 51. Brazil GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 52. EMEA GLP-1 Drug Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 53. EMEA GLP-1 Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 54. EMEA GLP-1 Drug Sales by Type (2018-2029) & (K Units)
Figure 55. EMEA GLP-1 Drug Sales Market Share in Volume by Type (2018-2029)
Figure 56. EMEA GLP-1 Drug Sales by Application (2018-2029) & (K Units)
Figure 57. EMEA GLP-1 Drug Sales Market Share in Volume by Application (2018-2029)
Figure 58. Europe GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 59. Middle East GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 60. Africa GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 61. China GLP-1 Drug Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 62. China GLP-1 Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 63. China GLP-1 Drug Sales by Type (2018-2029) & (K Units)
Figure 64. China GLP-1 Drug Sales Market Share in Volume by Type (2018-2029)
Figure 65. China GLP-1 Drug Sales by Application (2018-2029) & (K Units)
Figure 66. China GLP-1 Drug Sales Market Share in Volume by Application (2018-2029)
Figure 67. APAC GLP-1 Drug Sales in Volume Growth Rate 2018-2029 (K Units)
Figure 68. APAC GLP-1 Drug Sales in Value Growth Rate 2018-2029 (US$ Million)
Figure 69. APAC GLP-1 Drug Sales by Type (2018-2029) & (K Units)
Figure 70. APAC GLP-1 Drug Sales Market Share in Volume by Type (2018-2029)
Figure 71. APAC GLP-1 Drug Sales by Application (2018-2029) & (K Units)
Figure 72. APAC GLP-1 Drug Sales Market Share in Volume by Application (2018-2029)
Figure 73. Japan GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 74. South Korea GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 75. China Taiwan GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 76. Southeast Asia GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 77. India GLP-1 Drug Sales in Value Growth Rate (2018-2029) & (US$ Million)
Figure 78. GLP-1 Drug Value Chain
Figure 79. GLP-1 Drug Production Process
Figure 80. Channels of Distribution
Figure 81. Distributors Profiles
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
This report focuses on:
► Intelligent insights to take informed business decisions.
► Qualitative and quantitative analysis of the market.
► Market size and forecasts from 2024 to 2030.
► Opportunities for expansion and in-depth market analysis.
► Segmentation and regional revenue forecasts.
► Analysis of the market share and competitive landscape.
► Strategic recommendations for future growth.
You'll also receive:
► A comprehensive market research report in PDF or PPT formats.
► Access to our analysts to learn more about the report and get answers to your specific business questions.
► The option to customize the report to meet your specific needs, such as adding more countries or regions or developing abusiness case to launch a new product.
Contact us today to learn more and get sample report.
Our Research Reports Look Like This
